title: Microsporidial AIDS cholangiopathy due to Encephalitozoon intestinalis: case report and review.
abstract: Microsporidia are increasingly recognized as opportunistic infections in immunodeficient patients, predominantly patients with AIDS. The two microsporidia most commonly associated with disease in AIDS patients are Enterocytozoon bieneusi and Encephalitozoon intestinalis (previously known as Septata intestinalis). The most common clinical presentation of microsporidiosis in AIDS patients is diarrhea, most commonly caused by the Enterocytozoon bieneusi species. Encephalitozoon intestinalis is a recently described species that has been reported to cause disseminated human infection including cholangitis. We report a case of AIDS cholangiopathy that presented with abdominal pain and cholestatic liver tests. Ultrasound examination and ERCP revealed a picture of sclerosing cholangitis. Bile samples obtained at ERCP were negative for microsporidia; stool studies for microsporidia and cryptosporidia were also negative. No organisms were identified on routine light microscopy of the biopsy specimens from the duodenum, ampulla, and bile duct. E. intestinalis spores were demonstrated in the bile duct biopsies, by methylene blue and azure 11 staining and confirmed by electron microscopy. Albendazole therapy was successful in eradicating E. intestinalis with clinical improvement and improvement in CD4 count. However, the cholangiographic picture did not improve and repeat cholangiography revealed progressive bile duct injury. Albendazole therapy was delayed and may have been too late to prevent bile duct damage; the drug had to be approved by the US Food and Drug Administration for compassionate use. This is an unusual case of sclerosing cholangitis caused by an unusual organism and requiring biliary sphincterotomy and stent placement for progressive stricturing despite eradication of the infection.
authors.affiliation: Department of Internal Medicine, University of California Davis, Sacramento 95932, USA.
authors.forename: R A
authors.initials: RA
authors.lastname: Sheikh
authors.forename: T P
authors.initials: TP
authors.lastname: Prindiville
authors.forename: S
authors.initials: S
authors.lastname: Yenamandra
authors.forename: R J
authors.initials: RJ
authors.lastname: Munn
authors.forename: B H
authors.initials: BH
authors.lastname: Ruebner
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000469:parasitology*; D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001652:Bile Ducts / Q000469:parasitology / Q000648:ultrastructure; D001707:Biopsy, Needle; D002760:Cholangiopancreatography, Endoscopic Retrograde; D015209:Cholangitis, Sclerosing / Q000175:diagnosis / Q000188:drug therapy / Q000469:parasitology*; D003937:Diagnosis, Differential; D016819:Encephalitozoon / Q000302:isolation & purification*; D016890:Encephalitozoonosis / Q000175:diagnosis / Q000188:drug therapy / Q000469:parasitology*; D006801:Humans; D008297:Male
chemical_list: D000981:Antiprotozoal Agents; D015766:Albendazole